Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KB FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   3.3% 2.8% 2.7% 2.5% 2.1% 3.2% 13.2% 13.2%   Credit score (0-100)   56 60 60 60 66 55 17 17   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   1,067 1,107 858 1,106 0 0 0 0   Gross profit   570 729 505 693 916 0.0 0.0 0.0   EBITDA   144 172 90.3 123 198 53.3 0.0 0.0   EBIT   63.4 64.6 67.1 81.3 163 53.3 0.0 0.0   Pre-tax profit (PTP)   35.7 32.2 38.4 63.1 108.5 10.0 0.0 0.0   Net earnings   27.8 25.1 29.9 49.2 84.7 7.8 0.0 0.0   Pre-tax profit without non-rec. items   35.7 32.2 38.4 63.1 109 35.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,898 1,869 1,850 1,807 1,912 1,807 0.0 0.0   Shareholders equity total   506 593 562 611 609 618 471 471   Interest-bearing liabilities   2,112 1,831 1,546 1,266 1,498 1,339 0.0 0.0   Balance sheet total (assets)   2,838 2,733 2,477 2,289 2,589 2,534 471 471   Net Debt   1,993 1,718 1,445 1,071 1,474 1,272 -471 -471     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   1,067 1,107 858 1,106 0 0 0 0   Net sales growth   1.0% 3.7% -22.5% 28.9% -100.0% 0.0% 0.0% 0.0%   Gross profit   570 729 505 693 916 0.0 0.0 0.0   Gross profit growth   -6.7% 27.9% -30.7% 37.1% 32.2% -100.0% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,838 2,733 2,477 2,289 2,589 2,534 471 471   Balance sheet change%   -1.1% -3.7% -9.3% -7.6% 13.1% -2.1% -81.4% 0.0%   Added value   144.2 171.8 90.3 123.2 205.0 53.3 0.0 0.0   Added value %   13.5% 15.5% 10.5% 11.1% 0.0% 0.0% 0.0% 0.0%   Investments   -142 -136 -43 -84 70 -105 -1,807 0   Net sales trend   1.0 2.0 -1.0 1.0 -1.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   13.5% 15.5% 10.5% 11.1% 0.0% 0.0% 0.0% 0.0%   EBIT %   5.9% 5.8% 7.8% 7.3% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.1% 8.9% 13.3% 11.7% 17.8% 0.0% 0.0% 0.0%   Net Earnings %   2.6% 2.3% 3.5% 4.5% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   10.2% 11.9% 6.2% 8.2% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   3.3% 2.9% 4.5% 5.7% 0.0% 0.0% 0.0% 0.0%   ROA %   2.2% 2.3% 2.6% 3.4% 6.7% 2.1% 0.0% 0.0%   ROI %   2.3% 2.4% 2.8% 3.7% 7.0% 2.2% 0.0% 0.0%   ROE %   5.6% 4.6% 5.2% 8.4% 13.9% 1.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   17.8% 21.7% 22.7% 26.7% 23.5% 24.4% 100.0% 100.0%   Relative indebtedness %   207.6% 182.7% 204.3% 129.1% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   196.4% 172.6% 192.5% 111.4% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,382.7% 1,000.4% 1,600.4% 869.4% 744.0% 2,385.9% 0.0% 0.0%   Gearing %   417.8% 308.9% 275.3% 207.1% 245.8% 216.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.3% 1.6% 1.7% 1.3% 3.9% 1.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.0 2.9 2.5 3.3 1.4 1.2 0.0 0.0   Current Ratio   4.0 2.9 2.5 3.3 1.4 1.2 0.0 0.0   Cash and cash equivalent   119.2 112.4 101.5 195.3 23.8 67.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   39.4 42.7 55.2 34.3 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   49.7 119.1 74.4 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   88.1% 78.0% 73.1% 43.6% 0.0% 0.0% 0.0% 0.0%   Net working capital   615.9 462.6 287.9 246.5 184.5 98.7 0.0 0.0   Net working capital %   57.7% 41.8% 33.5% 22.3% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0